2019 Annual General Meeting

RNS Number : 6908D

Immupharma PLC

27 June 2019

 

                                                                                                                                                                      27 JUNE 2019

ImmuPharma PLC

("ImmuPharma" or the "Company")

2019 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.

-Ends-

For further information please contact: ImmuPharma PLC (www.immupharma.com) Tim McCarthy, Chairman + 44 (0) 207 152 4080 Dimitri Dimitriou, Chief Executive Officer Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496 SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Vassil Kirtchev Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson [phone] [phone] [phone]

 

END

 

 

AGMUBOURKVANUAR